1
|
Butini S, Nikolic K, Kassel S, Brückmann H, Filipic S, Agbaba D, Gemma S, Brogi S, Brindisi M, Campiani G, Stark H. Polypharmacology of dopamine receptor ligands. Prog Neurobiol 2016; 142:68-103. [PMID: 27234980 DOI: 10.1016/j.pneurobio.2016.03.011] [Citation(s) in RCA: 52] [Impact Index Per Article: 6.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/26/2015] [Revised: 01/26/2016] [Accepted: 03/15/2016] [Indexed: 01/11/2023]
Abstract
Most neurological diseases have a multifactorial nature and the number of molecular mechanisms discovered as underpinning these diseases is continuously evolving. The old concept of developing selective agents for a single target does not fit with the medical need of most neurological diseases. The development of designed multiple ligands holds great promises and appears as the next step in drug development for the treatment of these multifactorial diseases. Dopamine and its five receptor subtypes are intimately involved in numerous neurological disorders. Dopamine receptor ligands display a high degree of cross interactions with many other targets including G-protein coupled receptors, transporters, enzymes and ion channels. For brain disorders like Parkinsońs disease, schizophrenia and depression the dopaminergic system, being intertwined with many other signaling systems, plays a key role in pathogenesis and therapy. The concept of designed multiple ligands and polypharmacology, which perfectly meets the therapeutic needs for these brain disorders, is herein discussed as a general ligand-based concept while focusing on dopaminergic agents and receptor subtypes in particular.
Collapse
Affiliation(s)
- S Butini
- Department of Biotechnology, Chemistry and Pharmacy, European Research Centre for Drug Discovery and Development, University of Siena, Via Aldo Moro 2, 53100 Siena, Italy
| | - K Nikolic
- Department of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Belgrade, Vojvode Stepe 450, 11000 Belgrade, Serbia
| | - S Kassel
- Heinrich Heine University Duesseldorf, Institute of Pharmaceutical and Medicinal Chemistry, Universitaetsstr. 1, 40225 Duesseldorf, Germany
| | - H Brückmann
- Heinrich Heine University Duesseldorf, Institute of Pharmaceutical and Medicinal Chemistry, Universitaetsstr. 1, 40225 Duesseldorf, Germany
| | - S Filipic
- Department of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Belgrade, Vojvode Stepe 450, 11000 Belgrade, Serbia
| | - D Agbaba
- Department of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Belgrade, Vojvode Stepe 450, 11000 Belgrade, Serbia
| | - S Gemma
- Department of Biotechnology, Chemistry and Pharmacy, European Research Centre for Drug Discovery and Development, University of Siena, Via Aldo Moro 2, 53100 Siena, Italy
| | - S Brogi
- Department of Biotechnology, Chemistry and Pharmacy, European Research Centre for Drug Discovery and Development, University of Siena, Via Aldo Moro 2, 53100 Siena, Italy
| | - M Brindisi
- Department of Biotechnology, Chemistry and Pharmacy, European Research Centre for Drug Discovery and Development, University of Siena, Via Aldo Moro 2, 53100 Siena, Italy
| | - G Campiani
- Department of Biotechnology, Chemistry and Pharmacy, European Research Centre for Drug Discovery and Development, University of Siena, Via Aldo Moro 2, 53100 Siena, Italy
| | - H Stark
- Heinrich Heine University Duesseldorf, Institute of Pharmaceutical and Medicinal Chemistry, Universitaetsstr. 1, 40225 Duesseldorf, Germany.
| |
Collapse
|
2
|
Zhang Y, Liu F, Zhang X, Xu T, Quan W, Wang H, Shi J, Dai Z, Wu B, Wu Q. Recognition and identification of active components from Radix Bupleuri using human neuroblastoma SH-SY5Y cells. Biomed Chromatogr 2015; 30:440-6. [DOI: 10.1002/bmc.3567] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/16/2015] [Revised: 06/26/2015] [Accepted: 07/10/2015] [Indexed: 11/05/2022]
Affiliation(s)
- Yan Zhang
- Xian Mental Health Center; Xian Shaanxi China
- The Affiliated Mental Health Center of Xi'an School of Medicine; Xian Shaanxi China
| | - Feihu Liu
- Xian Mental Health Center; Xian Shaanxi China
- The Affiliated Mental Health Center of Xi'an School of Medicine; Xian Shaanxi China
| | - Xiaohong Zhang
- Xian Mental Health Center; Xian Shaanxi China
- The Affiliated Mental Health Center of Xi'an School of Medicine; Xian Shaanxi China
| | - Tanghui Xu
- The Affiliated No. 1 hospital of Xi'an School of Medicine; Xian Shaanxi China
| | - Wei Quan
- Xian Mental Health Center; Xian Shaanxi China
- The Affiliated Mental Health Center of Xi'an School of Medicine; Xian Shaanxi China
| | - Hui Wang
- Xian Mental Health Center; Xian Shaanxi China
- The Affiliated Mental Health Center of Xi'an School of Medicine; Xian Shaanxi China
| | - Jianguo Shi
- Xian Mental Health Center; Xian Shaanxi China
- The Affiliated Mental Health Center of Xi'an School of Medicine; Xian Shaanxi China
| | - Zunxiao Dai
- Xian Mental Health Center; Xian Shaanxi China
- The Affiliated Mental Health Center of Xi'an School of Medicine; Xian Shaanxi China
| | - Bin Wu
- Xian Mental Health Center; Xian Shaanxi China
- The Affiliated Mental Health Center of Xi'an School of Medicine; Xian Shaanxi China
| | - Qiangju Wu
- Xian Mental Health Center; Xian Shaanxi China
- The Affiliated Mental Health Center of Xi'an School of Medicine; Xian Shaanxi China
| |
Collapse
|